Evidence map›Paper›PMID 41492637›Full record

ArticleCureus2025

Monitoring Acute Posterior Multifocal Placoid Pigment Epitheliopathy Disease Progression Using Non-invasive Multimodal Imaging: A Case Series.

Andrew Palmier, Alastair Bezzina

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrew PalmierOphthalmology, Mater Dei Hospital, Msida, MLT.
Alastair BezzinaOphthalmology, Mater Dei Hospital, Msida, MLT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this case series, we present two cases of acute posterior multifocal placoid pigment epitheliopathy (APMPPE): a patient presenting for the first time with headaches and prodromal symptomatology associated with mild photophobia who was later diagnosed with APMPPE, and a patient who presented with a relapse of the same disease entity who was recently started on mycophenolate mofetil in view of previous macular involvement. In both cases, disease progression and therapeutic effect were assessed using non-invasive imaging, including optical coherence tomography (OCT) and fundus photography. Imaging biomarkers in keeping with disease resolution included a reduction in hyper-reflectivity in the outer plexiform layer (OPL) and outer nuclear layer (ONL) overlying the active placoid lesions on OCT, a progression from heterogeneous autofluorescent foci to smaller hypo-autofluorescent ones demonstrating a reduction in the outer retinal infiltrate and emergent retinal pigment epithelium dysfunction as well as a reduction in choriocapillaris flow voids on OCT angiography as the clinical picture improved. This case series and accompanying literature review help demonstrate the use of non-invasive imaging modalities in monitoring disease progression and screening for new disease activity in APMPPE without requiring the use of frequent dye-based angiography studies.

Indexed as

apmppecase seriesfundal autofluorescenceimagingoptical coherence angiographyoptical coherence tomographywhite dot syndromes

Identifiers

PMID41492637
PMCPMC12765517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.